Rheumnow Podcast
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Latest episodes
Jun 7, 2024 • 22min
Is Cannabis Safe? (6.7.2024)
Dr. Jack Cush reviews FDA approval, news and journal articles -- Its the week before EULAR 2024 in Vienna!!
May 31, 2024 • 19min
ACR’s Run at Goliath (PCPs) (5.31.2024)
Dr. Jack Cush reviews the journal reports and articles from this past week on RheumNow.com. The ACR (and Cush) address their new website designed to educate PCPs and APP's - what do you think?
May 24, 2024 • 21min
The Window of Opportunity (5.24.2024)
Dr. Jack Cush reviews the journal reports and news from the past week on RheumNow.com. This week blockbuster drugs, opioids in rheumatology and nontreatment of inflammatory arthritis?
May 17, 2024 • 24min
Don't You Know Who I am (5.17.2024)
Dr. Jack Cush reviews the news and journal reports from the past 2 weeks. This weeks question - Can we prevent gout, ILD or psoriasis?
May 11, 2024 • 23min
My Cancelled Lecture (5.11.2024)
In lieu of this weeks podcast, Dr. Jack Cush records his
"Life Lessons (that keep changing) in Rheumatology Lecture.
A lecture recently cancelled because some of this content was objectionable? (I dont think so!)
May 8, 2024 • 14min
Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs
The 2023 EULAR recommendations for the management of lupus advocate for a treat-to-target approach, aiming for remission or low-level disease activity state.3 In this video, Dr. Michelle Petri summarizes the clinical criteria to attain these targets, and their association with reducing organ damage accrual.
May 3, 2024 • 20min
Featured BSR Abstracts (5.3.2024)
Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.
May 2, 2024 • 17min
SLE Faculty Panel Q&A - Featuring Drs. David Karp, Michelle Kahlenberg, and Andrea Fava; moderated by Dr. Jack Cush
May 1, 2024 • 1h 5min
Tuesday Night Rheumatology- Mastering SLE
Experts David Karp, Michelle Kahlenberg, and Andrea Fava share insights on rethinking preclinical lupus, treating lupus flares, and using biomarkers for SLE management. Topics include B cell development, treatment approaches, complement activation, SLE therapy, biomarkers in lupus nephritis, and personalized medicine.
Apr 29, 2024 • 20min
